• LAST PRICE
    0.6855
  • TODAY'S CHANGE (%)
    Trending Up0.0254 (3.8479%)
  • Bid / Lots
    0.6855/ 1
  • Ask / Lots
    0.7260/ 9
  • Open / Previous Close
    0.6500 / 0.6601
  • Day Range
    Low 0.6500
    High 0.7000
  • 52 Week Range
    Low 0.5920
    High 15.0799
  • Volume
    119,770
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.6601
TimeVolumeCDAK
09:32 ET8090.655
09:46 ET2000.65
09:55 ET3710.6501
09:57 ET4000.6578
10:02 ET15200.658
10:08 ET1000.6561
10:11 ET4860.6579
10:13 ET1000.6579
10:22 ET2000.658
10:24 ET2450.65795
10:27 ET1000.6575
10:29 ET10010.6579
11:00 ET50150.6541
11:02 ET1500.6502
11:05 ET193000.6502
11:30 ET6000.6502
11:36 ET8000.658
11:38 ET11000.658
11:41 ET1000.6578
11:43 ET7810.6578
11:50 ET5110.658
11:52 ET100020.6843
11:54 ET171810.7
12:12 ET3200.6983
12:19 ET88780.6723
12:48 ET12000.6806
12:57 ET5000.6766
01:02 ET11300.676601
01:04 ET10200.68
01:06 ET24150.6834
01:13 ET1000.6863
01:20 ET45070.69
01:36 ET1000.6881
01:47 ET5000.7
02:02 ET1500.688201
02:16 ET1000.6882
02:32 ET1000.6881
02:36 ET2000.6891
02:38 ET29000.6891
02:39 ET2000.6801
02:45 ET8500.687525
02:50 ET21880.68505
03:01 ET2000.6899
03:06 ET56660.6802
03:10 ET1000.6851
03:12 ET2400.68612
03:32 ET6000.6899
03:35 ET56000.6852
03:37 ET50000.6852
03:39 ET7000.6805
03:44 ET1000.68525
03:46 ET1000.68525
03:50 ET1000.68525
03:51 ET3500.69
03:53 ET1000.68525
03:55 ET12000.6806
03:57 ET2000.6853
04:00 ET36150.6855
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCDAK
Codiak BioSciences, Inc.
25.2M
-1.0x
---
United StatesHARP
Harpoon Therapeutics Inc
24.6M
-0.3x
---
United StatesEMMA
Emmaus Life Sciences Inc
19.3M
-1.1x
---
United StatesOBSV
Obseva SA
15.5M
-0.2x
---
United StatesAGLE
Aeglea Bio Therapeutics Inc
30.8M
-0.4x
---
United StatesANGN
Angion Biomedica Corp
27.7M
-1.6x
---
As of 2022-12-04

Company Information

Codiak BioSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of exosome-based therapeutics. The Company has developed its engineering and manufacturing platform, engEx Platform, to develop upon the innate properties of exosomes to design, engineer and manufacture exosome therapeutics. It utilizes the engEx Platform to generate a pipeline of engineered exosomes (engEx) exosomes, focused at treating a range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease. The Company's product candidates, exoSTING and exoIL-12, are developed to address solid tumors. The Company's program, exoSTING, is an exosome therapeutic candidate engineered with its engEx Platform to carry stimulator of interferon genes (STING) agonist inside the lumen of the exosome while expressing prostaglandin F2 receptor negative regulator (PTGFRN).

Contact Information

Headquarters
35 CambridgePark Drive, Suite 500CAMBRIDGE, MA, United States 02140
Phone
617-949-4100
Fax
302-655-5049

Executives

Independent Chairman of the Board
Steven Gillis
President, Chief Executive Officer, Director
Douglas Williams
Chief Financial Officer, Treasurer
Linda Bain
Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary
Yalonda Howze
Senior Vice President - Human Resources
Nicole Barna

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$25.2M
Revenue (TTM)
$34.1M
Shares Outstanding
36.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.68
Book Value
$2.39
P/E Ratio
-1.0x
Price/Sales (TTM)
0.7
Price/Cash Flow (TTM)
---
Operating Margin
-58.76%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.